Synonyms: | |
Status: | Approved |
Entry Type: | Gene |
Molecule Category: | UKNOWN |
ATC: | L01XX51 |
UNII: | 07730V90L6 |
Action | Mechanism of Action | Reference |
---|---|---|
DISRUPTING AGENT | Melanoma cells disrupting agent | Other |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Melanoma | 3 | D008545 | ClinicalTrials |
Melanoma | 3 | D008545 | ClinicalTrials |
Sarcoma | 2 | D012509 | ClinicalTrials |
Sarcoma, Kaposi | 2 | D012514 | ClinicalTrials |
Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
Sarcoma | 2 | D012509 | ClinicalTrials |
Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Carcinoma, Intraductal, Noninfiltrating | 1 | D002285 | ClinicalTrials |
Head and Neck Neoplasms | 1 | D006258 | ClinicalTrials |
Glioma | 1 | D005910 | ClinicalTrials |
Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
Rectal Neoplasms | 1 | D012004 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL2108727 |
FDA SRS | 07730V90L6 |